Iris (Hongguang) Huo
About Iris (Hongguang) Huo
Iris (Hongguang) Huo is a Scientist I at ElevateBio, specializing in the differentiation of human pluripotent stem cells for regenerative medicine. She holds a BS in Chemical Engineering and a Master's in Biochemical Engineering, with extensive experience in molecular biology techniques and data analysis.
Work at ElevateBio
Iris Huo currently holds the position of Scientist I at ElevateBio, where she has been employed since 2021. Prior to this role, she served as Principal Associate Scientist in Regenerative Medicine at the same company from 2020 to 2021. Both positions are based in Waltham, Massachusetts, and involve significant contributions to the field of regenerative medicine.
Education and Expertise
Iris Huo obtained her Bachelor of Science in Chemical Engineering from East China University of Science and Technology, completing her studies from 1997 to 2001. She furthered her education by earning a Master's degree in Biochemical Engineering from the same institution from 2001 to 2004. Additionally, she earned another Master's degree in Chemical Engineering from the University of Delaware between 2004 and 2007. Her educational background supports her expertise in differentiating human pluripotent stem cells into various lineages, which is vital for regenerative medicine.
Background
Iris Huo has a diverse professional background in the biotechnology sector. She began her career as a Research Associate at Children's Hospital Boston from 2007 to 2010. She then worked at Ocata Therapeutics, first as a Scientist from 2010 to 2014 and later as Scientist II from 2014 to 2015. Following her tenure at Ocata, she joined Amgen as an Associate Scientist in Translational System Biology, where she worked from 2015 to 2020. Her career has been marked by a focus on regenerative medicine and advanced molecular biology techniques.
Technical Skills and Techniques
Iris Huo possesses a broad technical skill set that includes proficiency in advanced molecular biology techniques such as CRISPR/Cas9 gene editing and ddPCR. These techniques are essential for precise genetic modifications and quantification. Additionally, she is skilled in high content imaging using Operetta/Phoenix for detailed cellular analysis and has experience in developing quantitative phenotypic assays, which are important for drug discovery. She also utilizes software tools like Geneious and FlowJo for data analysis in genetics and flow cytometry.
Professional Experience
Iris Huo has accumulated extensive experience across various roles in the biotechnology field. Her work history includes significant positions at Ocata Therapeutics, Amgen, and ElevateBio, where she has contributed to advancements in regenerative medicine and molecular biology. Her roles have involved both research and application of techniques critical to understanding cellular behavior and developing therapeutic strategies.